Introduction of ventilators for neonates were one of the time changing and life-saving innovations that manufacturers developed to provide life-saving support for neonates having respiratory ailments. With advances in medical technologies, such as replacement surfactant therapy and administration of antepartum corticosteroids, neonatal ventilators have improved the infant survival quotient, specifically for preterm infants that suffer from immature functioning of lungs.
An insight based research report on neonatal ventilator market by a leading research firm – FactMR – reveals that the market for neonatal ventilator is projected to expand at a value CAGR of 5.6% throughout the period of assessment, 2018-2028.
Concern for Respiratory Health Grows With Increasing Number of Preterm Births and Mortality Rates
Preterm births are one of the leading causes of infant mortality, especially due to respiratory failures in neonates. Developed countries such as United States have witnessed a significant growth in preterm births since past decade. In the United States witnessed a 2 percent increase in the preterm birth rate, which is expected to further increase in the coming years.
Mortality rate associated with preterm births is largely due insufficient care in terms of respiratory monitoring and nutrition consumption. Moreover, lungs of neonates are small in size that require additional support for regulating their respiration. This has led to the adoption of neonatal ventilators that can provide the required amount of oxygen to the lungs, sufficient enough for neonates to survive even in ill respiratory conditions. According to analysis of United Nations Children’s Fund (UNICEF), around 2.6 million deaths were observed worldwide in the first month of birth. The increasing mortality rate is a clear growth determinant for the use of neonatal ventilators which is a positive growth influencer for neonatal ventilator market during the period of forecast.
NICUs to Present Lucrative Growth Opportunities
Neonatal Intensive Care Units (NICUs), particularly developed for providing extreme care for neonates have witnessed an increase in the number of admissions. In United Kingdom, around 95,000 babies are born in NICUs owing to higher preterm births in the country. In addition, with the growing preterm birth statistics, the number of NICUs have also increased with higher intake capacity and enhanced patient care facilities. This is expected to auger well for the neonatal ventilator market with respect to high volume sales of the product in NICUs across various regions.
Lung Injuries Associated With Neonatal Ventilators – a Major Challenge
Neonatal ventilators used for supporting respiratory function of the infant can result in lung injuries owing to excess airway pressure, flow, tidal volume, inflammatory and infection mediators coupled with recurring closing and opening of alveoli. Lungs of neonates being smaller in size and not completely developed, their injuries can lead to critical complications such as BPD (Bronchopulmonary Dysplasia), even death owing to respiratory failure. This has challenged the use of neonatal ventilators and is expected to hinder the growth of the neonatal ventilator market.
However, addressing this challenge, manufacturers have developed techniques to reduce the occurrence of lung injuries. Continued efforts have been carried out, particularly focused on developing new technologies that include the adoption of early CPAP (Continuous Positive Airway Pressure) in neonates that are at risk from neonatal RDS (Respiratory Distress Syndrome) as well as techniques to maintain adequate gas exchange to reduce lung injuries.